Bank of America
TBXU

Bank of America’s Direxion Daily Biotech Top 5 Bull 2X ETF TBXU Stock Holding History

Bank of America’s Portfolio TBXU Stock Details TBXU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803K Hold
25,000
– – ﹤0.01% 4726
2026
Q1 		$784K Hold
25,000
– – ﹤0.01% 4640
2025
Q4 		$777K Buy
+25,000
New +$747K ﹤0.01% 4664

Other funds holding TBXU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America's TBXU Position: Q2 2026 in Review

Bank of America held its Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) position steady in Q2 2026 at 25,000 shares worth $803K. The position accounts for ﹤0.01% of the portfolio, ranked #4726.

Bank of America first reported a position in TBXU in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold TBXU as of Q2 2026.

  • Bank of America held 25,000 shares of Direxion Daily Biotech Top 5 Bull 2X ETF worth $803K as of Q2 2026.
  • Bank of America left its Direxion Daily Biotech Top 5 Bull 2X ETF share count unchanged in Q2 2026.
  • Direxion Daily Biotech Top 5 Bull 2X ETF made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4726 holding.
  • Bank of America first reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF in Q4 2025 and has held it in 3 quarters since.
  • 4 funds tracked by Wall St. Rank held Direxion Daily Biotech Top 5 Bull 2X ETF as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.